Dermatology: Practical and Conceptual Original Article | Dermatol Pract Concept. 2022;12(4):e2022163 1 Videodermoscopic Changes of the Hair in Vitiligo Lesions in Relation to Disease Duration Tag Anbar1, Hamza Abdelraouf1, Ahmed Abd Elfattah Afify2, Maha Hussien Ragaie1, Amira Abulfotooh Eid3, Hoda Moneib2 1 Department of Dermatology and Venereology, Faculty of Medicine, Al-Minya University, Al-Minya, Egypt 2 Department of Dermatology, and Venereology, Faculty of Medicine, Ain Shams University, Cairo, Egypt 3 Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt Key words: vitiligo, videodermoscopy, hair changes, alopecia areata incognita Citation: Anbar T, Abdelraouf H, Afify AA, Ragaie MH, Eid AA, Moneib H. Videodermoscopic changes of the hair in vitiligo lesions in relation to disease duration. Dermatol Pract Concept. 2022;12(4):e2022163. DOI: https://doi.org/10.5826/dpc.1204a163 Accepted: January 30, 2022; Published: October 2022 Copyright: ©2022 Anbar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution- NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Amira Abulfotooh Eid, Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Elazarita 21521, Alexandria, Egypt. Tel: +2 03 4872150 E-mail: amira.eid@alexmed.edu.eg; dramiraeid@yahoo.co.uk Introduction: Vitiligo is an acquired disease of complex pathogenesis, in which the immunologic attack to the skin and hair follicle melanocytes leads to areas of depigmentation and leukotrichia, respectively. Objectives: To study the dermoscopic features of the hair changes in vitiligo lesions in comparison to perilesional control areas and in relation to disease duration. Methods: Forty-seven patients with both old and recent vitiligo lesions were included. Dermoscopic features of hair within the lesions were examined and compared to those in perilesional non depigmented skin of the same patient. Results: Hair density (P < 0.001), terminal hair rate (P = 0.011), terminal to vellus hair ratio (P = 0.029) and mean hair shaft thickness (P = 0.031) were significantly decreased, whereas vellus hair rate (P = 0.011) was significantly increased in old vitiligo lesions compared to their respective control areas. The frequency of broken hair was significantly higher in old lesions (P < 0.001), while that of upright re-growing hair was significantly higher in recent lesions (P = 0.016). Conclusions: Hair involvement in vitiligo lesions is not only limited to the development of leukotrichia. Other subtle changes in hair density, anagen and telogen hair rates, and mean hair thickness can be detected. These changes may serve as objective clues to the duration of the lesions. ABSTRACT 2 Original Article | Dermatol Pract Concept. 2022;12(4):e2022163 Introduction Vitiligo is an acquired chronic depigmenting autoimmune disease of the skin and hair; in which progressive destruction of melanocytes occur. Loss of melanocytes from the epidermis is the cause of leukoderma, and if the process extends to involve the active bulbar melanocytes, leukotrichia will de- velop [1]. In addition to the characteristic skin involvement in vitiligo, other associated manifestations including ocular and audiological findings have been described. [2-4]. Several theories have been put forward to explain the etiopathogenesis of vitiligo; among which autoimmunity is the leading one. The increased prevalence of several autoim- mune diseases in vitiligo patients as well as their first degree relative has been reported, which suggests a general genetic predisposition to autoimmunity [4,5]. One of the commonly associated autoimmune diseases with vitiligo is alopecia areata (AA) [6]. Both diseases have common genetic risk fac- tors and share certain similarities regarding their pathogene- sis [7,8]. Several reports of colocalization of vitiligo and AA especially on the scalp exist in the literature [9-12], with skin biopsies exhibiting features of both diseases [12]. Moreover, relatively decreased hair density was previously reported in a depigmented area on the scalp that was also associated with histopathologic features suggestive of AA [13]. On revising the literature, no studies detailing the dermoscopic features of the hair in vitiligo lesions in different body areas could be found. Objectives The objective of this study was to explore the dermoscopic features of the hair in vitiligo lesions in different body sites and their relation to disease duration. Methods This study included 47 non segmental vitiligo patients of both sexes with more than one patch of vitiligo. Exclusion criteria for lesion choice: 1. Lesions in areas anatomically known to have absent or sparse hair, eg palms, soles, mucous membranes, fingers and dorsum of the foot. 2. Scalp lesions, as it is difficult to evaluate vitiligo without shaving due to high hair density. 3. If all lesions in the same patient were of less than or more than two-year duration. 4. Segmental vitiligo. 5. Patients with a concomitant diagnosis of AA or with his- tory of previously developing AA. An informed consent was signed by each patient after the technical and scientific basis of the research project and the steps of the procedure were explained in details. The research was approved by the local Medical Ethics Committee (approval number: 0303878/14/03/2018). Each patient was examined clinically and two vitiligo le- sions (one old and one recent) were selected for examination; recent lesions were of a duration of less than two years and old lesions were of a duration of two or more years [14]. Lesions and surrounding control areas were photographed using a digital camera (Samsung ST66, 16 megapixels); photos were taken from a constant distance and under sim- ilar photographing conditions. The hair within the lesions was evaluated using the Medicam 1000 video- dermoscope (Fotofinder). Three shots were taken with the video- dermoscope (20X magnification) from the vitiligo lesion and three shots were taken from perilesional normally pigmented skin (control) after Wood’s light examination was done to exclude the presence of subclinical vitiligo. The dermoscopic photos were evaluated by Trichoscale® Pro program (Fotofinder). The report of every photo included data about hair density, anagen and telogen hair rates, terminal and vellus hair rates and the mean hair shaft thickness. The means of the collected data from the reports of the three shots taken from every lesional and perilesional normally pigmented skin were determined. In addition, videodermoscopic photos of the studied lesions and perilesional control areas were evaluated for the presence of dermoscopic signs of alopecia areata such as black dots, tapering hair, broken hair, yellow dots, short vellus hair, circular (pigtail) hair, upright re- growing hair and Pohl-Pinkus constriction. Statistical Analysis The collected data was analyzed using the statistical package for Social Science (IBM SPSS Statistics for Windows, Version 22.0; IBM Corp.). Quantitative variables were tested for normality of distribution using the Kolmogorov-Smirnov test and were expressed as median and interquartile range (IQR). Categorical variables were expressed as frequencies and percentages. Paired nominal variables were compared using McNemar-Bowker test. Differences between paired continuous data (lesions and control areas) were tested using the Wilcoxon signed rank test. The strength of association between the two quantitative vari- ables was assessed using Spearman method. A P value less than 0.05 was considered statistically significant. Results The age of the patients ranged from 7 to 55 years (mean: 26.38 ± 14.5 years). Twenty-four males (51%) and 23 females (49%) were enrolled in the study. The mean duration of the Original Article | Dermatol Pract Concept. 2022;12(4):e2022163 3 included recent vitiligo lesions (< 2 years) was 6.28 ± 2.37 months while the mean duration of the included old vitiligo lesions (≥ 2 years ) was 46.8 ± 18.72 months. Hair Changes in Recent Lesions In recent vitiligo lesions, anagen hair rate, anagen to telogen ratio, terminal hair rate and terminal to vellus ratio were lower than those in the respective control areas, but the difference was not significant (P = 0.352, 0.783, 0.603 and 0.656, respectively). Furthermore, hair density, telogen hair rate, and vellus hair rate were higher in recent vitiligo lesions compared to control areas, and the difference was also not significant (P = 0.151, 0.352 and 0.603, respectively) (Table 1). Hair Changes in Old Lesions In old vitiligo lesions, hair density, terminal hair rate, termi- nal to vellus ratio and mean hair thickness were significantly lower (P < 0.001, 0.011, 0.029 and 0.031, respectively), whereas vellus hair rate was significantly higher (p=0.011) than in the perilesional control areas. No significant differ- ence between old patches and their control areas regarding anagen and telogen hair rates and anagen to telogen ratio was detected (P = 0.195, 0.195 and 0.357, respectively) (Table 2). The decrease in hair density and thickness in old vitiligo lesions compared to their respective control sites is shown in Figure 1. Dermoscopic Signs of the Hair in Vitiligo Lesions In old lesions, the most commonly encountered sign was bro- ken hair, which was seen in 51.1% of the patients, followed by pig tail hair in 31.9% of the patients. Meanwhile, tapering hair and Pohl-Pinkus constriction were the least commonly encountered signs, as each was detected in 8.5% of patients. In recent vitiligo patches, short vellus hair was detected in 31.9% of the patients followed by upright re-growing hair in 29.8% of the patients. The least commonly encountered sign was tapering hair that was detected in 4.3% of the patients. None of the recent vitiligo patches showed Pohl-Pinkus constriction. The presence of broken hair was significantly higher, whereas the presence of upright regrowing hair was significantly lower in old patches compared to recent patches (P <0.001 and 0.016, respectively) (Table 3). On comparing old vitiligo lesions to their respective controls, the frequency Table 1. Comparison between hair changes in recent vitiligo patches and their respective control patches. Recent patches (N = 47) Control of recent patches (N = 47) P Hair density (hair/cm2) 52.00 (23.20 – 81.90) 45.40 (17.70 – 96.30) 0.151 Anagen hair rate (%) 51.70 (33.10 – 65.30) 53.50 (37.50 – 66.70) 0.352 Telogen hair rate (%) 48.30 (34.70 – 66.90) 46.50 (33.30 – 62.50) 0.352 Anagen to telogen ratio 1.07 (0.49 – 1.88) 1.15 (0.60 – 2.0) 0.783 Terminal hair rate (%) 5.60 (0.0 – 19.40) 6.70 (0.0 – 18.0) 0.603 Vellus hair rate (%) 94.40 (80.60 – 100.0) 93.30 (82.0 – 100.0) 0.603 Terminal to vellus ratio 0.06 (0.0 – 0.24) 0.07 (0.0 – 0.22) 0.656 Mean thickness (mm) 0.028 (0.026 – 0.031) 0.028 (0.025 – 0.031) 0.414 Data are expressed as median (interquartile range); P value for Wilcoxon Signed Ranks Test. Table 2. Comparison between hair changes in old vitiligo patches and their respective control patches. Old patches (N = 47) Control of old patches (N = 47) p Hair density (hair/cm2) 33.20 (12.20 – 56.50) 78.60 (26.60 – 156.10) < 0.001 Anagen hair rate (%) 48.10 (40.0 – 70.60) 61.60 (45.60 – 70.20) 0.195 Telogen hair rate (%) 51.90 (29.40 – 60.0) 38.40 (29.80 – 54.40) 0.195 Anagen to telogen ratio 0.92 (0.67 – 2.40) 1.60 (0.84 – 2.36) 0.357 Terminal hair rate (%) 10.30 (0.0 – 19.30) 17.10 (8.80 – 38.50) 0.011 Vellus hair rate (%) 89.70 (80.70 – 100.0) 82.90 (61.50 – 91.20) 0.011 Terminal to vellus ratio 0.11 (0.0 – 0.24) 0.21 (0.10 – 0.63) 0.029 Mean thickness (mm) 0.029 (0.025 – 0.031) 0.031 (0.029 – 0.035) 0.031 Data are expressed median (interquartile range); P value for Wilcoxon Signed Ranks Test 4 Original Article | Dermatol Pract Concept. 2022;12(4):e2022163 Figure 1. Decreased hair density and thickness in old vitiligo lesions compared to their respective control sites (magnification x20). (A-C) Videodermoscopic photos of the hair changes in the old vitiligo lesions. (D-F) Video-dermoscopic photos of respective control sites. (A, B, D and E on the nape, C and F on the leg). Table 3. Comparison between old and recent vitiligo patches regarding dermoscopic features of alopecia areata incognita. Old patches (N =4 7) Recent patches (N = 47) P Black dots, N (%) 6 (12.8%) 9 (19.1%) 0.250 Tapering hair, N (%) 4 (8.5%) 2 (4.3%) 0.500 Broken hair, N (%) 24 (51.1%) 8 (17.0%) < 0.001 Yellow dots, N (%) 8 (17%) 6 (12.8%) 0.500 Short vellus hair, N (%) 11 (23.4%) 15 (31.9%) 0.125 Circular (pig tail) hair, N (%) 15 (31.9%) 11 (23.4%) 0.125 Upright re-growing hair, N (%) 7 (14.9%) 14 (29.8%) 0.016 Pohl-Pinkus constrictions, N (%) 4 (8.5%) 0 (0.0%) 0.125 P for McNemar-Bowker test Original Article | Dermatol Pract Concept. 2022;12(4):e2022163 5 been attributed to an increase in cytotoxic CD8+NKG2D+ T cells together with over expression of interferon gamma (IFN-γ), with the involvement of the JAK-STAT signaling pathway [8]. In addition, it has been shown that the immu- nologic attack of CD8+ T-cells on follicular melanocytes can in some instances result in both depigmentation and hair loss [28]. Clinically, the fact that non-pigmented hairs are usually spared in alopecia areata, and regrowing hairs are initially depigmented, further links alopecia areata to mela- nocytes [29]. It has been proposed that autoreactive T-cells against melanogenesis-associated proteins are responsible for spar- ing white hairs in AA and for the transient regrowth of hypo-pigmented hairs. However, there is always an exception to the rule; as in some patients non-pigmented hairs were lost as well, and in others re-growing white hairs persisted. Furthermore, some patients never experience hair regrowth following the initial attack. These different outcomes suggest the existence of various antigens and various pathways in- volved that ultimately determine the fate of the immunologic attack on the hair follicle [30]. Unlike the findings of Walker et al. [13], hairs within the examined lesions were not exclusively depigmented, and in addition to decreased density, they also exhibited decreased thickness and decreased terminal to vellus ratio owing to an increase in vellus hair rate and a decrease in terminal hair rate. These changes, however, were only detected in old le- sions. Unfortunately, the software program used in the cur- rent study digitally documents the essential hair parameters of all hairs in the lesion regardless of their color; accordingly, determining if the detected changes were influenced by hair color was not possible. The role of disease duration in vitiligo has been previ- ously studied and the presence of melanocytes in the hair follicles in vitiligo lesions was reported to be inversely correlated with disease duration [31]. In addition, shorter disease durations were associated with better treatment re- sponse to phototherapy [32]. In the present study, old and recent vitiligo lesions were compared with their respective controls. All significant videodermoscopic hair changes were exclusively seen in old vitiligo lesions. These findings further point to the possible influence of disease duration in vitiligo. It seems that the insult to vitiligo skin is done through two waves with two different onsets, a first wave affecting epidermal melanocytes resulting in leukoderma, followed by a second wave affecting the hair leading to subtle hair changes, and if the insult of this wave is severe enough, leukotrichia can occur. The possibility that these hair changes could be the forerunners of leukotrichia remains to be determined. To conclude, this study demonstrated that the hair in- volvement within vitiligo patches is not merely a color of broken hair, yellow dots and pig tail hair was significantly higher in the former (P < 0.001, 0.031, 0.004, respectively). Meanwhile, black dots and pig tail hair were significantly higher in recent vitiligo lesions than in control areas (P = 0.004 and 0.031, respectively). Conclusions In vitiligo, skin involvement usually precedes hair involve- ment. Nevertheless, lesions where leukotrichia developed prior to skin depigmentation have been reported, which was believed to result from preferential involvement of follicular melanocytes in such cases [15,16]. Several changes have been reported in association with vitiligo that include ocular, auditory and even nail changes [2,3,17]. Apart from the color change, little is known about the changes that could occur in the hair within vitiligo lesions. Reports of AA and vitiligo existing in the same individual are present [18], and several reports of co-localization of vitiligo and AA exist in the literature, most of which describe com- plete loss of hair in the depigmented patch with few white peripheral hairs. On histopathologic examination of the in- volved areas, features of vitiligo and AA were detected. Most of these cases were reported in young age and were mostly located on the scalp [9-12,19]. Walker et al. reported slight reduction in hair density within a localized area of poliosis on the scalp with depigmentation of the underlying skin in a male patient. Skin biopsies revealed features of both vitiligo and AA [13]. However, none of those reports studied the der- moscopic hair changes within the vitiligo lesions. In the present study, the anagen-to-telogen and the terminal-to-vellus ratios were lower in both old and recent areas compared to their respective controls but the differ- ence was significant only in the terminal-to-vellus ratio in old lesions. Furthermore, both old and recent vitiligo lesions exhibited dermoscopic findings such as yellow dots, bro- ken hair, short vellus hair, upright regrowing hair and cir- cular hair. These detected changes exhibit a certain degree of similarity to hair changes previously reported in alope- cia areata incognita (AAI), which is characterized by the absence of a smooth bald surface, increased telogen hairs [20], yellow dots, upright regrowing hairs [21], black dots, short vellus hair, broken hair, and tapered hair [21-24]. AAI usually shows increased proportion of telogen and vellus hairs [25], resulting in decreased terminal-to-vellus and an- agen-to-telogen ratios in patients compared to normal sub- jects [21,26,27]. The similarities between hair changes detected in the present study and those reported in AAI could be explained by the proposed immunologic link between vitiligo and AA; as both diseases are considered cell mediated autoimmune diseases in which disease induction, at least in part, has 6 Original Article | Dermatol Pract Concept. 2022;12(4):e2022163 13. Walker A, Mesinkovska NA, Boncher J, Tamburro J, Bergfeld WF. Colocalization of vitiligo and alopecia areata presenting as poliosis. J Cutan Pathol. 2015;42(2):150-154. DOI: 10.1111 /cup.12437. PMID: 25388912. 14. Brazzelli V, Antoninetti M, Palazzini S, Barbagallo T, De Silvestri A, Borroni G. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. J Eur Acad Dermatol Venereol. 2007;21(10):1369-1374. DOI: 10.1111/j.1468- 3083.2007.02278.x. PMID: 17958843. 15. Gan EY, Cario-Andre M, Pain C, et al. Follicular vitiligo: A report of 8 cases. J Am Acad Dermatol. 2016;74(6):1178-1184. DOI: 10.1016/j.jaad.2015.12.049. PMID: 26830867. 16. Tobin DJ. The cell biology of human hair follicle pigmenta- tion. Pigment Cell Melanoma Res. 2011;24(1):75-88. DOI: 10.1111/j.1755-148X.2010.00803.x. PMID: 21070612. 17. Anbar T, Hay RA, Abdel-Rahman AT, Moftah NH, Al-Khayyat MA. Clinical study of nail changes in vitiligo. J Cosmet Dermatol. 2013;12(1):67-72. DOI: 10.1111/jocd.12022. PMID: 23438144. 18. Gopal KV, Rama Rao GR, Kumar YH, Appa Rao MV, Vasudev P. Vitiligo: a part of a systemic autoimmune process. Indian J Dermatol Venereol Leprol. 2007;73(3):162-165. DOI: 10.4103/0378-6323.32710. PMID: 17558047. 19. Dhar S, Kanwar AJ. Colocalization of vitiligo and alopecia areata. Pediatr Dermatol. 1994;11(1):85-86. DOI: 10.1111 /j.1525-1470.1994.tb00089.x. PMID: 8170863. 20. Rebora A. Alopecia areata incognita: a hypothesis. Dermatologica. 1987;174(5):214-218. DOI: 10.1159/000249182. PMID: 2953 632. 21. Tosti A, Whiting D, Iorizzo M, et al. The role of scalp dermos- copy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol. 2008;59(1):64-67. DOI: 10.1016/j.jaad.2008.03.031. PMID: 18440667. 22. Peter D, George L, Pulimood SA. Trichoscopic features of vari- ous types of alopecia areata in India: application of a hand-held dermoscope. Australas J Dermatol. 2013;54(3):198-200. DOI: 10.1111/j.1440-0960.2012.00942.x. PMID: 22943070. 23. Hegde SP, Naveen KN, Athanikar SB, Reshme P. Clinical and dermatoscopic patterns of alopecia areata: a tertiary care cen- tre experience. Int J Trichology. 2013;5(3):132-136. DOI: 10.4103/0974-7753.125608. PMID: 24574691; PMCID: PMC 3927170. 24. Waskiel A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Trichoscopy of alopecia areata: An update. J Dermatol. 2018;45(6):692-700. DOI: 10.1111/1346-8138.14283. PMID: 29569271. 25. Molina L, Donati A, Valente NS, Romiti R. Alopecia areata in- cognita. Clinics (Sao Paulo). 2011;66(3):513-5. DOI: 10.1590/ s1807-59322011000300027. PMID: 21552683. PMCID: PMC 3072018. 26. Miteva M, Misciali C, Fanti PA, Tosti A. Histopathologic features of alopecia areata incognito: a review of 46 cases. J Cutan Pathol. 2012;39(6):596-602. DOI: 10.1111/j.1600-0560.2012.01896.x . PMID: 22616601. 27. Whiting DA. Histopathologic features of alopecia areata: a new look. Arch Dermatol. 2003;139(12):1555-1559. DOI: 10.1001 /archderm.139.12.1555. PMID: 14676070. 28. Nagai H, Oniki S, Oka M, Horikawa T, Nishigori C. Induction of cellular immunity against hair follicle melanocyte causes alo- pecia. Arch Dermatol Res. 2006;298(3):131-134. DOI: 10.1007 /s00403-006-0668-y. PMID: 16786344. change, and that these changes may serve as an objective clue to the duration of vitiligo lesions. The resemblance be- tween the detected changes and some of the known features of AAI adds a new item to the list of similarities between AA and vitiligo. Accordingly, further research combining dermoscopic examination with histopathologic evaluation of the hair changes in vitiligo lesions and studying the re- lation of these changes to disease activity and severity is recommended. References 1. Chatterjee M, Neema S, Vasudevan B, Dabbas D. Eyelash Trans- plantation for the Treatment of Vitiligo Associated Eyelash Leucotrichia. J Cutan Aesthet Surg. 2016;9(2):97-100. DOI: 10.4103/0974-2077.184042. PMID: 27398010; PMCID: PMC4924422. 2. Bulbul Baskan E, Baykara M, Ercan I, Tunali S, Yucel A. Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol. 2006;20(7):829-833. DOI: 10.1111/j.1468 -3083.2006.01655.x. PMID: 16898906. 3. Anbar TS, El-Badry MM, McGrath JA, Abdel-Azim ES. Most individuals with either segmental or non-segmental vitiligo dis- play evidence of bilateral cochlear dysfunction. Br J Derma- tol. 2015;172(2):406-411. DOI: 10.1111/bjd.13276. PMID: 25041189. 4. Iannella G, Greco A, Didona D, et al. Vitiligo: Pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2016;15(4):335-43. DOI: 10.1016/j.autrev.2015.12.006. PMID: 26724277. 5. Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77(1):1-13. DOI: 10.1016/j .jaad.2016.10.048. PMID: 28619550. 6. Hordinsky M, Ericson M. Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc. 2004;9(1):73-78. DOI: 10.1111/j.1087-0024.2004.00835.x. PMID: 14870990. 7. Rork JF, Rashighi M, Harris JE. Understanding autoimmunity of vitiligo and alopecia areata. Curr Opin Pediatr. 2016;28(4):463- 469. DOI: 10.1097/MOP.0000000000000375. PMID: 27191 524. PMCID: PMC4957563. 8. Harris JE. Vitiligo and alopecia areata: apples and oranges? Exp Dermatol. 2013;22(12):785-789. DOI: 10.1111/exd.12264. PMID: 24131336. PMCID: PMC3867815. 9. Adams BB, Lucky AW. Colocalization of alopecia areata and vitiligo. Pediatr Dermatol. 1999;16(5):364-366. DOI: 10.1046/j.1525-1470.1999.00094.x. PMID: 10571834. 10. Kumar S, Mittal J, Mahajan B. Colocalization of vitiligo and alopecia areata: coincidence or consequence? Int J Trichology. 2013;5(1):50-52. DOI: 10.4103/0974-7753.114705. PMID: 23960402. PMCID: PMC3746232. 11. Ozcan D, Cevlik Aydogan F. Concurrence of alopecia areata and vitiligo at the same anatomical site. Australas J Dermatol. 2012;53(3):e61-E63. DOI: 10.1111/j.1440-0960.2011.00778.x. PMID: 22881476. 12. Krishnaram AS, Saigal A, Adityan B. Alopecia areata - Vitiligo overlap syndrome: an emerging clinical variant. Indian J Dermatol Venereol Leprol. 2013;79(4):535-537. DOI: 10.4103/0378-6323.113100. PMID: 23760330. Original Article | Dermatol Pract Concept. 2022;12(4):e2022163 7 31. Anbar TS, Abdel-Raouf H, Awad SS, Ragaie MH, Abdel-Rahman AT. The hair follicle melanocytes in vitiligo in relation to disease duration. J Eur Acad Dermatol Venereol. 2009;23(8):934-939. DOI: 10.1111/j.1468-3083.2009.03233.x. PMID: 19453793. 32. Anbar TS, Westerhof W, Abdel-Rahman AT, El-Khayyat MA. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites. Photoder- matol Photoimmunol Photomed. 2006;22(3):157-163. DOI: 10.1111/j.1600-0781.2006.00222.x. PMID: 16719871. 29. Jia WX, Mao QX, Xiao XM, Li ZL, Yu RX, Li CR. Patchy alo- pecia areata sparing gray hairs: a case series. Postepy Dermatol Alergol. 2014;31(2):113-116. DOI: 10.5114/pdia.2014.40956. PMID: 25097478. PMCID: PMC4112253. 30. Asz-Sigall D, Ortega-Springall MF, Smith-Pliego M, et al. White hair in alopecia areata: Clinical forms and proposed physio- pathological mechanisms. J Am Acad Dermatol. 2019:S0190- 9622(19)30010-S0190-9622(19)30016. DOI: 10.1016/j.jaad.2018 .12.047. PMID: 30630022.